Apr 1, 2025 · Agency Program Coordinators, or APCs, manage day-to-day operations of the travel card program for an organization and serve as the primary liaisons between the travel cardholder and the Government Travel Charge Card (GTCC) vendor.

GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.

Oct 10, 2024 · Mutations in the APC gene have been found to occur in most colorectal cancers, where disease-associated mutations tend to be clustered in a small region designated the mutation cluster region (MCR) and result in a truncated protein product. [provided by RefSeq, Jun 2022] Go to nucleotide Graphics FASTA GenBank.

The researchers conducted a split-mouth randomized clinical trial to compare the effects of treating periodontal intrabony defects with GTR with and without autogenous platelet concentrate (APC).

Nov 26, 2018 · There is very low-quality evidence that the adjunct of APC to OFD or OFD + BG when treating infrabony defects may improve probing pocket depth, clinical attachment level, and radiographic bone defect filling. For GTR or EMD, insufficient evidence of an advantage in using APC was observed.

BTR (Russian: БТР), from Bronetransportyor / Bronetransporter (Russian: бронетранспортёр / Ukrainian: бронетранспортер; literally "armoured transporter"), is any of a series of Soviet or post-Soviet military armoured personnel carriers (APCs). BTR-40 – Armoured 4×4 truck (1950s) based on GAZ-63 four wheel drive truck.

Jun 28, 2019 · Study selection Parallel and split-mouth randomised controlled trials (RCTs) conducted on patients with infrabony defects requiring surgical treatment were considered. Studies needed to compare a...

Objectives: To investigate the influence of autogenous platelet concentrate (APC) on the long-term regeneration outcome 7 years after guided tissue regeneration (GTR) in deep intrabony periodontal defects.

Setup Parallel measurements with a dual line APC xApp (CS, 10 nm and 23 nm AVL CPCs) and an APC plus (ET, 23 nm AVL CPC) at the tailpipe. 10 tests of G-DI vehicles driven over different cycles (WLTC, NEDC, FTP75, USO6).

Aim: To investigate the clinical long-term outcomes 13 years following guided tissue regeneration (GTR) in deep intra-bony defects with and without additional application of autogenous platelet concentrate (APC).